UFP Technologies Inc. filings document operating results and material events for its medical-device contract development and manufacturing business. Form 8-K reports furnish quarterly and annual earnings releases, non-GAAP financial measures, Regulation FD investor presentation materials, material definitive agreements with strategic medical customers, cybersecurity incident disclosures, and executive succession and compensation arrangements.
Proxy filings cover board elections, executive compensation, equity awards, pay-versus-performance disclosure, and shareholder voting matters. These records frame the company's governance, capital and incentive structure, customer-contract disclosures, and public reporting obligations as a Nasdaq-listed operating company.
UFP Technologies reported record 2025 results, with net income of $68.3 million, up 15.8% from 2024, and net sales of $602.8 million, a 19.5% increase. GAAP diluted EPS rose to $8.75, while adjusted EPS reached $9.76.
Growth was driven by a 23.2% increase in medical-market sales to $555.3 million, while non-medical sales fell 11.5% to $47.5 million. Organic sales growth for 2025 was 1.5%, reflecting a significant contribution from acquisitions.
Gross margin slipped to 28.3% from 29.1%, pressured by about $6.3 million of labor-related inefficiencies at the AJR facility. Even so, operating income climbed 14.1% to $92.3 million, adjusted EBITDA increased to $121.1 million, and long-term debt declined from $176.9 million to $123.0 million, strengthening the balance sheet.
UFP Technologies outlined compensation changes tied to its leadership transition and 2026 incentive programs. The board confirmed an Employment Offer Letter for Mitchell C. Rock, who becomes Chief Executive Officer on June 4, 2026, with a $700,000 base salary, an annual bonus opportunity up to 100% of salary, and long‑term incentive awards in restricted stock units.
Rock will receive a one‑time $650,000 RSU grant and, beginning in 2027, will be eligible for annual LTI awards targeted at up to $3,000,000 in RSUs. His severance agreement provides 18 months of base salary and COBRA reimbursement if terminated without cause or for good reason, and enhanced cash and full equity vesting upon a qualifying change of control.
The Compensation Committee also raised 2026 base salaries for senior executives and granted stock unit and performance share awards with multi‑year vesting and performance conditions. Outgoing CEO R. Jeffrey Bailly received 19,061 stock units, described as $5.1 million in value, vesting in 2027, along with a 2026 performance bonus plan and continued equity protections under his existing agreement.
UFP Technologies Vice President Jason Holt reported stock-based awards that increase his direct ownership. On February 10, 2026, he acquired 657 shares of common stock at $0 upon achievement of performance targets tied to restricted stock units originally granted on February 11, 2025. He also received 1,121 time-based stock unit awards on the same date at $0, all under the company’s 2003 Incentive Plan.
These units are to be settled solely in common shares and vest in equal one-third installments on March 1 dates from 2026 through 2029, contingent on continued employment. Following these awards, Holt directly beneficially owns 9,456 shares of UFP Technologies common stock.
UFP Technologies Senior Vice President Christopher P. Litterio reported stock-based awards tied to company performance and service. On February 10, 2026, he acquired 821 shares of common stock at $0, reflecting performance-based restricted stock units granted on February 11, 2025 under the 2003 Incentive Plan.
He also acquired 1,215 shares at $0 from time-based stock unit awards granted on February 10, 2026. After these awards, he directly held 12,792 shares of common stock. The performance units vest in thirds each March 1 from 2026 through 2028, and the time-based units vest in thirds each March 1 from 2027 through 2029, contingent on continued employment.
UFP Technologies president Mitchell Rock reported equity awards that increase his direct holdings. On February 10, 2026, he acquired 2,463 shares of common stock for $0 upon performance-based restricted stock units granted on February 11, 2025 being certified as achieved, bringing his holdings to 35,463 shares. On the same date, he received an additional 3,270 time-based stock units for $0, raising his direct ownership to 38,733 shares. The performance-based units vest one-third on March 1, 2026 and one-third on each of March 1, 2027 and March 1, 2028, subject to continued employment. The time-based units vest one-third on March 1, 2027 and one-third on each of March 1, 2028 and March 1, 2029 if he remains employed.
UFP Technologies Chief Financial Officer Ronald J. Lataille reported stock-based awards that increase his direct common stock holdings. On February 10, 2026, he acquired 2,463 shares at $0 per share upon achievement of performance targets under the 2003 Incentive Plan, bringing his direct holdings to 15,460 shares.
He also acquired 3,115 time-based stock unit awards to be settled solely in common shares at $0 per share, increasing his direct holdings reported to 18,575 shares. The performance-based units vest in three equal installments on March 1, 2026, 2027, and 2028, while the time-based awards vest in three equal installments on March 1, 2027, 2028, and 2029, subject to continued employment. In addition to these direct holdings, he also owns 38,940 shares of UFP Technologies, Inc. indirectly.
UFP Technologies CEO R. Jeffrey Bailly reported equity awards of common stock on February 10, 2026. He acquired 7,428 restricted stock units tied to 2025 performance goals and 19,061 time-based stock units granted under the company’s 2003 Incentive Plan, all to be settled in common shares.
Following these grants, Bailly directly held 179,585 shares of common stock. A footnote also notes an additional 28,706 shares held indirectly by a trust, with beneficial ownership disclaimed except for any pecuniary interest.
Wasatch Advisors filed an amended Schedule 13G showing a significant ownership position in UFP Technologies, Inc. common stock. Wasatch reports beneficial ownership of 782,708 shares, representing 10.1% of the outstanding class as of the event date.
The firm has sole voting power over 537,721 shares and sole dispositive power over all 782,708 shares, with no shared voting or dispositive power. Wasatch certifies the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of UFP Technologies.
UFP Technologies (UFPT) reported insider activity by a senior vice president. On 11/06/2025, the officer sold a total of 1,829 shares of common stock in multiple trades, with weighted-average sale prices across tranches ranging from $219.82 to $232.29. Following these sales, the reporting person directly owned 10,756 shares.
UFP Technologies (UFPT) reported steady Q3 performance with strong year‑to‑date momentum. Net sales were $154.6 million versus $145.2 million a year ago, and net income was $16.4 million compared with $16.4 million. For the first nine months, sales rose to $453.9 million from $360.4 million, with net income up to $50.7 million from $42.6 million as recent acquisitions contributed meaningfully.
Gross profit increased in Q3 to $42.7 million, though operating income softened to $23.4 million. Diluted EPS was $2.11 in Q3 and $6.52 year‑to‑date. Operating cash flow strengthened to $75.1 million for the nine months, supporting lower borrowings under the credit facilities. Total debt was $146.1 million at quarter‑end, and cash was $18.2 million. Medical end‑markets comprised 92.1% of Q3 sales, reflecting the company’s focus on single‑use medical devices.
UFPT continued integrating acquisitions. In 2025 it acquired Techno Plastics Industries for $4.5 million and Universal Plastics & Engineering Company for $7.5 million. 2024 acquisitions included AJR Enterprises ($110.0 million), Welch Fluorocarbon ($34.6 million), AQF (€43 million), and Marble Medical ($4.5 million). Customer concentration remained notable, with two customers accounting for 27.1% and 17.1% of Q3 sales.